Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Antimicrobial Agents and Chemotherapy|July 1, 2015
Pharmacokinetics and pharmacodynamics of continuous-infusion meropenem in pediatric hematopoietic stem cell transplant patientsPiergiorgio Cojutti, Natalia Maximova, Federico Pea
Clinical Pharmacokinetics|July 4, 2014
Levofloxacin dosing regimen in severely morbidly obese patients (BMI ≥40 kg/m(2)) should be guided by creatinine clearance estimates based on ideal body weight and optimized by therapeutic drug monitoringManjunath P Pai, Piergiorgio Cojutti, Federico Pea
Clinical Pharmacokinetics|April 9, 2015
Pharmacokinetics and pharmacodynamics of continuous infusion meropenem in overweight, obese, and morbidly obese patients with stable and unstable kidney function: a step toward dose optimization for the treatment of severe gram-negative bacterial infectionsManjunath P Pai, Piergiorgio Cojutti, Federico Pea
Clinical Pharmacokinetics|October 30, 2017
Population Pharmacokinetics and Dosing Considerations for the Use of Linezolid in Overweight and Obese Adult PatientsPiergiorgio Cojutti, Manjunath P Pai, Federico Pea
International Journal of Antimicrobial Agents|May 13, 2017
Limited sampling strategies for determining the area under the plasma concentration-time curve for isoniazid might be a valuable approach for optimizing treatment in adult patients with tuberculosisPiergiorgio Cojutti, Manuela Giangreco, Miriam Isola, et al.
Therapeutic Drug Monitoring|March 19, 2014
Stability of generic meropenem solutions for administration by continuous infusion at normal and elevated temperaturesLoretta Franceschi, Piergiorgio Cojutti, Massimo Baraldo, et al.
Antimicrobial Agents and Chemotherapy|October 10, 2012
Dosing nomograms for attaining optimum concentrations of meropenem by continuous infusion in critically ill patients with severe gram-negative infections: a pharmacokinetics/pharmacodynamics-based approachFederico Pea, Pierluigi Viale, Piergiorgio Cojutti, et al.
British Journal of Clinical Pharmacology|October 16, 2015
A 1 year retrospective audit of quality indicators of clinical pharmacological advice for personalized linezolid dosing: one stone for two birds?Federico Pea, Piergiorgio Cojutti, Lucia Dose, et al.
Pharmacoepidemiology and Drug Safety|May 18, 2016
Polytherapy and the risk of potentially inappropriate prescriptions (PIPs) among elderly and very elderly patients in three different settings (hospital, community, long-term care facilities) of the Friuli Venezia Giulia region, Italy: are the very elderly at higher risk of PIPs?Piergiorgio Cojutti, Luca Arnoldo, Giovanni Cattani, et al.
Expert Opinion on Drug Metabolism & Toxicology|October 10, 2017
Clinical and pharmacokinetic drug evaluation of delafloxacin for the treatment of acute bacterial skin and skin structure infectionsMatteo Bassetti, Davide Pecori, Piergiorgio Cojutti, et al.
Pageof 4